The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 601–700 of 1,037
Ibrahim, S. J. A., & Thangamani, M. (2019) · Measurement · doi:10.1016/j.measurement.2019.02.056 · Cited by 103
Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Palve, V. C., Liao, Y., Rix, L. L. R., & Rix, U. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.003 · Cited by 103
A new method for computational drug repositioning using drug pairwise similarity
Li, J., & Lu, Z. (2012) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2012.6392722 · Cited by 103
miRNA Profiling Discriminates Types of Rejection and Injury in Human Renal Allografts
Wilflingseder, J., Regele, H. M., Perco, P., Kainz, A., Soleiman, A., Mühlbacher, F., Mayer, B., & Oberbauer, R. W. (2013) · Transplantation · doi:10.1097/tp.0b013e318280b385 · Cited by 103
Large‐scale prediction of drug–target relationships
Kuhn, M., Campillos, M., González, P., Jensen, L. J., & Bork, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.024 · Cited by 89
Minireview: Global Regulation and Dynamics of Ribonucleic Acid
Keene, J. D. (2010) · Endocrinology · doi:10.1210/en.2009-1250 · Cited by 90
A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans
Calvert, S., Tacutu, R., Sharifi, S., Teixeira, R., Ghosh, P., & de Magalhães, J. P. (2016) · Aging Cell · doi:10.1111/acel.12432 · Cited by 94
PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens
Bush, E. C., Ray, F., Alvarez, M. J., Realubit, R., Li, H., Karan, C., Califano, A., & Sims, P. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00136-z · Cited by 107
The metabolomics of asthma control: a promising link between genetics and disease
McGeachie, M. J., Dahlin, A., Qiu, W., Croteau‐Chonka, D. C., Savage, J. R. K., Wu, A. C., Wan, E. S., Sordillo, J. E., Al-Garawi, A. A., Martínez, F. D., et al. (2015) · Immunity Inflammation and Disease · doi:10.1002/iid3.61 · Cited by 102
eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription
Brina, D., Miluzio, A., Ricciardi, S., Clarke, K., Davidsen, P. K., Viero, G., Tebaldi, T., Offenhäuser, N., Rozman, J., Rathkolb, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9261 · Cited by 102
Luo, S., Li, H., Mo, Z., Lei, J., Zhu, L., Huang, Y., Fu, R., Li, C., Huang, Y., Liu, K., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0229-z · Cited by 102
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L., Leverenz, J. B., Cummings, J., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 94
Alijagić, A., Kotlyar, O., Larsson, M., Salihović, S., Hedbrant, A., Eriksson, U., Karlsson, P. G., Persson, A., Scherbak, N. N., Färnlund, K., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108412 · Cited by 102
Shameer, K., Readhead, B., & Dudley, J. T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150112103510 · Cited by 102
Turanlı, B., Zhang, C., Kim, W., Benfeitas, R., Uhlén, M., Arğa, K. Y., & Mardinoğlu, A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.009 · Cited by 103
Shin, D., Lee, W., Lee, J. H., & Bang, D. (2019) · Science Advances · doi:10.1126/sciadv.aav2249 · Cited by 101
Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Harrill, J., Shah, I., Setzer, R. W., Haggard, D., Auerbach, S., Judson, R., & Thomas, R. S. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.05.004 · Cited by 101
Amelio, I., Gostev, M., Knight, R. A., Willis, A. E., Melino, G., & Antonov, A. V. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.9 · Cited by 101
Janssens, G. E., Lin, X.-X., Millan-Ariño, L., Kavšek, A., Sen, I., Seinstra, R. I., Stroustrup, N., Nollen, E. A. A., & Riedel, C. G. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.044 · Cited by 94
iDEP Web Application for RNA-Seq Data Analysis
Ge, X. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1307-8_22 · Cited by 101
Using the Zebrafish Photomotor Response for Psychotropic Drug Screening
Kokel, D., & Peterson, R. T. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-381320-6.00022-9 · Cited by 101
Tangen, I. L., Werner, H. M. J., Berg, A., Halle, M. K., Kusonmano, K., Trovik, J., Høivik, E. A., Mills, G. B., Krakstad, C., & Salvesen, H. B. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.003 · Cited by 101
Tan, B. S., Kang, O., Mai, C., Tiong, K. H., Khoo, A. S. B., Pichika, M. R., Bradshaw, T. D., & Leong, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.014 · Cited by 101
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
Raetz, E. A., & Bhatla, T. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.129.3800156 · Cited by 101
de Vargas, D. M., Bastiani, M. A. D., Zimmer, E. R., & Klamt, F. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0394-7 · Cited by 101
Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
Kingsmore, K. M., Grammer, A. C., & Lipsky, P. E. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0337-0 · Cited by 100
Role of miR-2392 in driving SARS-CoV-2 infection
McDonald, J. T., Enguita, F. J., Taylor, D. M., Griffin, R. J., Priebe, W., Emmett, M. R., Sajadi, M. M., Harris, A. D., Clement, J., Dybas, J. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109839 · Cited by 101
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Winter, G. E., Rix, U., Carlson, S. M., Gleixner, K. V., Grebien, F., Gridling, M., Müller, A. C., Breitwieser, F. P., Bilban, M., Colinge, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1085 · Cited by 97
Protein localization as a principal feature of the etiology and comorbidity of genetic diseases
Park, S., Yang, J., Shin, Y., Park, J. M., Jang, S. K., & Kim, S. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.29 · Cited by 101
Boolean network modeling in systems pharmacology
Bloomingdale, P., Nguyen, V. A., Niu, J., & Mager, D. E. (2018) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9567-4 · Cited by 100
The future of antibiotics begins with discovering new combinations
Zhu, M., Tse, M. W., Weller, J., Chen, J., & Blainey, P. C. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14649 · Cited by 99
Cheng, F., Hong, H., Yang, S., & Wei, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw051 · Cited by 99
Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment
Levey, D. F., Niculescu, E. M., Le-Niculescu, H., Dainton‐Howard, H., Phalen, P. L., Ladd, T. B., Weber, H., Belanger, E. A., Graham, D. L., Khan, F., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.31 · Cited by 98
Biological Activities of Gedunin—A Limonoid from the Meliaceae Family
Braga, T. M., Rocha, L., Chung, T. Y., de Oliveira, R. F. F., Pinho, C., Oliveira, A. I., Morgado, J., & Cruz, A. (2020) · Molecules · doi:10.3390/molecules25030493 · Cited by 98
Morphological profiling of small molecules
Ziegler, S., Sievers, S., & Waldmann, H. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.012 · Cited by 98
Systematic synergy modeling: understanding drug synergy from a systems biology perspective
Chen, D., Liu, X., Yang, Y., Yang, H., & Lu, P. (2015) · BMC Systems Biology · doi:10.1186/s12918-015-0202-y · Cited by 98
Li, J. J., Tay, H. L., Maltby, S., Xiang, Y., Eyers, F., Hatchwell, L., Zhou, H., Toop, H. D., Morris, J. C., Nair, P. K., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.044 · Cited by 100
Houghton, P. J., Morton, C. L., Gorlick, R. G., Lock, R. B., Carol, H., Reynolds, C. P., Kang, M. H., Maris, J. M., Keir, S. T., Kolb, E. A., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0952 · Cited by 98
Lean Big Data integration in systems biology and systems pharmacology
Ma’ayan, A., Rouillard, A. D., Clark, N. R., Wang, Z., Duan, Q., & Kou, Y. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.07.001 · Cited by 91
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
Pawar, G. V., Madden, J. C., Ebbrell, D. J., Firman, J. W., & Cronin, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00561 · Cited by 97
Liu, J., Geng, R., Ni, S., Cai, L., Yang, S., Shao, F., & Bai, J. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.01.018 · Cited by 102
Chen, L., Niu, X., Qiao, X., Liu, S., Ma, H., Shi, X., He, X., & Zhong, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739039 · Cited by 97
Hahn, C. K., Ross, K. N., Warrington, I. M., Mazitschek, R., Kanegai, C. M., Wright, R. D., Kung, A. L., Golub, T. R., & Stegmaier, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710413105 · Cited by 91
Self-citationCoordinated posttranscriptional mRNA population dynamics during T‐cell activation
Mukherjee, N., Lager, P. J., Friedersdorf, M. B., Thompson, M. A., & Keene, J. D. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.44 · Cited by 86
Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures
Lee, H., Kang, S., & Kim, W. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150460 · Cited by 90
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer
Yochum, Z. A., Cades, J., Mazzacurati, L., Neumann, N. M., Khetarpal, S. K., Chatterjee, S., Wang, H., Attar, M. A., Huang, E. H. ‐., Chatley, S. N. H., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0298 · Cited by 97
Lau, K. S., Juchheim, A. M., Cavaliere, K., Philips, S. R., Lauffenburger, D. A., & Haigis, K. M. (2011) · Science Signaling · doi:10.1126/scisignal.2001338 · Cited by 96
Bruni, G. N., Lakhani, P., & Kokel, D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00153 · Cited by 96
HSP90 as a platform for the assembly of more effective cancer chemotherapy
Whitesell, L. J., & Lin, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.006 · Cited by 96
Rapid learning for precision oncology
Shrager, J., & Tenenbaum, J. M. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.244 · Cited by 95
Computational Drug Repurposing: Current Trends
Karaman, B., & Sippl, W. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530100332 · Cited by 96
Zhao, K., & So, H. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2856535 · Cited by 96
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Gao, K., Wang, R., Chen, J., Cheng, L., Frishcosy, J., Huzumi, Y., Qiu, Y., Schluckbier, T., Wei, X., & Wei, G. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00965 · Cited by 95
Self-citationLv, C., Huang, Y., Wang, Q., Wang, C., Hu, H., Zhang, H., Lu, D., Jiang, H., Shen, R., Zhang, W., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2023.02.003 · Cited by 95
Stumpel, D. J. P. M., Schneider, P., Seslija, L., Osaki, H., Williams, O., Pieters, R., & Stam, R. W. (2011) · Leukemia · doi:10.1038/leu.2011.278 · Cited by 95
Systems pharmacology and genome medicine: a future perspective
Wist, A. D., Berger, S., & Iyengar, R. (2009) · Genome Medicine · doi:10.1186/gm11 · Cited by 97
Delahaye-Duriez, A., Srivastava, P., Shkura, K., Langley, S. R., Laaniste, L., Moreno-Moral, A., Danis, B., Mazzuferi, M., Foerch, P., Gazina, E. V., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1097-7 · Cited by 86
Le-Niculescu, H., Roseberry, K., Gill, S. S., Levey, D. F., Phalen, P. L., Mullen, J., Williams, A., Bhairo, S., Voegtline, T., Davis, H., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01061-w · Cited by 94
“We also used the biomarker gene expression signatures to interrogate the Connectivity Map database from Broad/MIT, and the NIH LINCS database, in order to identify drugs and natural compounds that can be repurposed for treating and preventing depression, including bipolar depression.”
MethodInfluentialRexach, J. E., Polioudakis, D., Yin, A., Swarup, V., Chang, T. S., Nguyen, T., Sarkar, A., Chen, L., Huang, J., Lin, L.-C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108398 · Cited by 94
Zhang, P., Wang, F., & Hu, J. (2014) · PubMed Central · Cited by 94
Li, J., Song, P., Jiang, T., Dai, D., Wang, H., Sun, J., Zhu, L., Xu, W., Feng, L., Shin, V. Y., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.014 · Cited by 95
DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration
Wang, Y., Yang, Y., Chen, S., & Wang, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab048 · Cited by 94
Liu, J., Chen, C., Wang, Y., Qian, C., Wei, J., Xing, Y., & Bai, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746647 · Cited by 96
A complementary role for ELF3 and TFL1 in the regulation of flowering time by ambient temperature
Strasser, B., Alvarez, M. J., Califano, A., & Cerdán, P. D. (2009) · The Plant Journal · doi:10.1111/j.1365-313x.2009.03811.x · Cited by 94
Wang, Y., Liu, Z., Li, C., Li, D., Ouyang, Y., Yu, J., Guo, S., He, F., & Wang, W. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/698531 · Cited by 94
Computational drug repositioning for rare diseases in the era of precision medicine
Delavan, B., Roberts, R., Huang, R., Bao, W., Tong, W., & Liu, Z. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2017.10.009 · Cited by 85
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
Xiang, Z., Liu, J., Shi, D., Chen, W., Li, J., Yan, R., Bi, Y., Hu, W., Zhu, Z., Yu, Y., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47652 · Cited by 93
Bai, S., Wu, Y., Yan, Y., Shao, S., Zhang, J., Liu, J., Hui, B., Liu, R., Ma, H., Zhang, X., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70484-2 · Cited by 93
Wang, H., Li, S., Wang, Q., Jin, Z., Shao, W., Gao, Y., Li, L., Lin, K., Zhu, L., Wang, H., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd7851 · Cited by 93
Lambertz, I., Kumps, C., Claeys, S., Lindner, S., Beckers, A., Janssens, E., Carter, D. R., Cazes, A., Cheung, B. B., Mariano, M. D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2024 · Cited by 96
Fang, H., Zeng, H., Lin, L.-M., Chen, X., Shen, X., Fu, P., Lv, C., Liu, Q., Liu, R., Zhang, W., et al. (2017) · Scientific Reports · doi:10.1038/srep43632 · Cited by 93
Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
Silva, M. C., & Haggarty, S. J. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14012 · Cited by 83
Self-citationUse of big data in drug development for precision medicine: an update
Qian, T., Zhu, S., & Hoshida, Y. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1617632 · Cited by 94
Network-based characterization of drug-regulated genes, drug targets, and toxicity
Kotlyar, M., Fortney, K., & Jurisica, I. (2012) · Methods · doi:10.1016/j.ymeth.2012.06.003 · Cited by 92
Oshida, K., Vasani, N., Jones, C., Moore, T., Hester, S., Nesnow, S., Auerbach, S., Geter, D. R., Aleksunes, L. M., Thomas, R. S., et al. (2015) · Nuclear Receptor Signaling · doi:10.1621/nrs.13002 · Cited by 85
Fang, J., Wu, Z., Cai, C., Wang, Q., Tang, Y., & Cheng, F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00216 · Cited by 92
Ferraro, M., D’Annessa, I., Moroni, E., Morra, G., Paladino, A., Rinaldi, S., Compostella, F., & Colombo, G. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00825 · Cited by 93
Systems biology based drug repositioning for development of cancer therapy
Turanlı, B., Altay, Ö., Borén, J., Türkez, H., Nielsen, J., Uhlén, M., Arğa, K. Y., & Mardinoğlu, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.020 · Cited by 92
Multi-target drugs for Alzheimer's disease
Turgutalp, B., & Kızıl, Ç. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.05.005 · Cited by 92
Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide
Johannessen, T.-C. A., Hasan‐Olive, M. M., Zhu, H., Denisova, O. V., Grudic, A., Latif, A., Saed, H. S., Varughese, J. K., Røsland, G. V., Yang, N., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31912 · Cited by 92
mTOR regulates autophagy-associated genes downstream of p73
Rosenbluth, J. M., & Pietenpol, J. A. (2009) · Autophagy · doi:10.4161/auto.5.1.7294 · Cited by 86
Song, P., Feng, L., Li, J., Dai, D., Zhu, L., Wang, C., Li, J., Li, L., Zhou, Q., Shi, R., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01244-z · Cited by 91
Computational analyses of mechanism of action (MoA): data, methods and integration
Trapotsi, M.-A., Hosseini-Gerami, L., & Bender, A. (2022) · RSC Chemical Biology · doi:10.1039/d1cb00069a · Cited by 71
Artificial intelligence in microbial natural product drug discovery: current and emerging role
Sahayasheela, V. J., Lankadasari, M. B., Dan, V. M., Dastager, S. G., Pandian, G. N., & Sugiyama, H. (2022) · Natural Product Reports · doi:10.1039/d2np00035k · Cited by 91
Proteomic discovery of chemical probes that perturb protein complexes in human cells
Lazear, M. R., Remsberg, J. R., Jaeger, M. G., Rothamel, K. L., Her, H.-L., DeMeester, K. E., Njomen, E., Hogg, S. J., Rahman, J. A., Whitby, L. R., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.03.026 · Cited by 93
Molecular mechanisms underlying variations in lung function: a systems genetics analysis
Obeidat, M., Hao, K., Bossé, Y., Nickle, D. C., Nie, Y., Postma, D. S., Laviolette, M., Sandford, A. J., Daley, D., Hogg, J. C., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00380-x · Cited by 91
Compound signature detection on LINCS L1000 big data
Liu, C., Su, J., Yang, F., Wei, K., Ma, J., & Zhou, X. (2015) · Molecular BioSystems · doi:10.1039/c4mb00677a · Cited by 81
Rho, S. B., Kim, B.-R., & Kang, S. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.10.003 · Cited by 91
Lee, H. S., Bae, T., Lee, J.-H., Kim, D. G., Oh, Y. S., Jang, Y., Kim, J.-T., Lee, J.-J., Innocenti, A., Supuran, C. T., et al. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-80 · Cited by 87
dos Santos, S. C., Teixeira, M. C., Cabrito, T. R., & Sá‐Correia, I. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00063 · Cited by 93
Drug repurposing for the treatment of glioblastoma multiforme
Abbruzzese, C., Matteoni, S., Signore, M., Cardone, L., Nath, K., Glickson, J. D., & Paggi, M. G. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0642-x · Cited by 86
Towards systematic functional characterization of cancer genomes
Boehm, J. S., & Hahn, W. C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3013 · Cited by 91
Duarte, Y., Márquez‐Miranda, V., Miossec, M. J., & González-Nilo, F. D. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1554 · Cited by 90
Evaluation of connectivity map shows limited reproducibility in drug repositioning
Lim, N., & Pavlidis, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-97005-z · Cited by 90
Progress in toxicogenomics to protect human health
Meier, M. J., Harrill, J., Johnson, K. J., Thomas, R. S., Tong, W., Rager, J. E., & Yauk, C. L. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00767-1 · Cited by 90
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis
Perne, A., Muellner, M. K., Steinrueck, M., Craig-Mueller, N., Mayerhofer, J., Schwarzinger, I., Sloane, M., Uras, I. Z., Hoermann, G., Nijman, S. M. B., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008292 · Cited by 83
Cleavage-based signal amplification of RNA
Zhao, Y., Zhou, L., & Tang, Z. (2013) · Nature Communications · doi:10.1038/ncomms2492 · Cited by 90
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
Kim, S. Y., Dunn, I. F., Firestein, R., Gupta, P. B., Wardwell, L., Repich, K., Schinzel, A. C., Wittner, B. S., Silver, S. J., Root, D. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008979 · Cited by 91
Self-citationLitichevskiy, L., Peckner, R., Abelin, J. G., Asiedu, J. K., Creech, A. L., Davis, J. F., Davison, D., Dunning, C. M., Egertson, J. D., Egri, S., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.03.012 · Cited by 87
Self-citation
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.